Swedish Orphan (Germany) Price Prediction
| B6E Stock | EUR 26.48 0.04 0.15% |
Oversold Vs Overbought
53
Oversold | Overbought |
Using Swedish Orphan hype-based prediction, you can estimate the value of Swedish Orphan Biovitrum from the perspective of Swedish Orphan response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Swedish Orphan to buy its stock at a price that has no basis in reality. In that case, they are not buying Swedish because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Swedish Orphan after-hype prediction price | EUR 26.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Swedish |
Swedish Orphan After-Hype Price Prediction Density Analysis
As far as predicting the price of Swedish Orphan at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Swedish Orphan or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Swedish Orphan, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Swedish Orphan Estimiated After-Hype Price Volatility
In the context of predicting Swedish Orphan's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Swedish Orphan's historical news coverage. Swedish Orphan's after-hype downside and upside margins for the prediction period are 24.20 and 28.76, respectively. We have considered Swedish Orphan's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Swedish Orphan is not too volatile at this time. Analysis and calculation of next after-hype price of Swedish Orphan Biovitrum is based on 3 months time horizon.
Swedish Orphan Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Swedish Orphan is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Swedish Orphan backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Swedish Orphan, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 2.28 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
26.48 | 26.48 | 0.00 |
|
Swedish Orphan Hype Timeline
Swedish Orphan Biovitrum is currently traded for 26.48on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Swedish is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at -0.07%. %. The volatility of related hype on Swedish Orphan is about 0.0%, with the expected price after the next announcement by competition of 26.48. About 70.0% of the company shares are held by institutions such as insurance companies. The book value of Swedish Orphan was currently reported as 3.55. The company had not issued any dividends in recent years. Assuming the 90 days horizon the next estimated press release will be in 5 to 10 days. Check out Swedish Orphan Basic Forecasting Models to cross-verify your projections.Swedish Orphan Related Hype Analysis
Having access to credible news sources related to Swedish Orphan's direct competition is more important than ever and may enhance your ability to predict Swedish Orphan's future price movements. Getting to know how Swedish Orphan's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Swedish Orphan may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ZOE | Zoetis Inc | 0.00 | 0 per month | 0.00 | (0.12) | 1.83 | (2.22) | 5.97 | |
| TKD | Takeda Pharmaceutical | 0.00 | 0 per month | 0.00 | (0.10) | 1.85 | (1.57) | 5.14 | |
| EII | Eisai Co | 0.00 | 0 per month | 0.00 | (0.18) | 3.57 | (4.55) | 21.10 | |
| SH0 | Shionogi Co | 0.00 | 0 per month | 0.00 | (0.02) | 1.68 | (2.46) | 26.16 | |
| 0C8 | Catalent | 0.00 | 0 per month | 0.35 | 0.15 | 1.77 | (0.81) | 5.51 | |
| TEV | Teva Pharmaceutical Industries | 0.00 | 0 per month | 1.46 | 0.14 | 4.43 | (3.15) | 25.97 | |
| I7G | Ipsen SA | 0.00 | 0 per month | 0.00 | (0.05) | 2.17 | (2.61) | 6.57 | |
| RDDA | Dr Reddys Laboratories | 0.00 | 0 per month | 1.43 | 0.01 | 2.84 | (2.22) | 6.92 | |
| B6E | Swedish Orphan Biovitrum | 0.00 | 0 per month | 0.00 | (0.05) | 1.99 | (3.35) | 18.15 |
Swedish Orphan Additional Predictive Modules
Most predictive techniques to examine Swedish price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Swedish using various technical indicators. When you analyze Swedish charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Swedish Orphan Predictive Indicators
The successful prediction of Swedish Orphan stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Swedish Orphan Biovitrum, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Swedish Orphan based on analysis of Swedish Orphan hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Swedish Orphan's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Swedish Orphan's related companies.
Story Coverage note for Swedish Orphan
The number of cover stories for Swedish Orphan depends on current market conditions and Swedish Orphan's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Swedish Orphan is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Swedish Orphan's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Swedish Orphan Short Properties
Swedish Orphan's future price predictability will typically decrease when Swedish Orphan's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Swedish Orphan Biovitrum often depends not only on the future outlook of the potential Swedish Orphan's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Swedish Orphan's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 295.1 M |
Complementary Tools for Swedish Stock analysis
When running Swedish Orphan's price analysis, check to measure Swedish Orphan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Swedish Orphan is operating at the current time. Most of Swedish Orphan's value examination focuses on studying past and present price action to predict the probability of Swedish Orphan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Swedish Orphan's price. Additionally, you may evaluate how the addition of Swedish Orphan to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |